# Articles Expert insights and practical perspectives on drug safety. Read the latest Qinecsa articles and partner contributions covering pharmacovigilance, clinical safety, signal and risk management, and regulatory topics. #### [The Productivity Crisis That Persists Even Now: What Will It Take to Free Up PV Professionals to Assess Safety, Rather Than Coordinate Data?](/content/resources/the-productivity-crisis-that-persists-even-now-what-will-it-take-to-free-up-pv-professionals-to-assess-safety-rather-than-coordinate-data/index.html) July 28, 2026 #### [Embracing quantitative signal detection methods as a smaller MAH](/content/resources/embracing-quantitative-signal-detection-methods-as-a-smaller-mah/index.html) June 25, 2026 #### [Real-Time Safety Signals Drive Continuous PV Insight](/content/articles/real-time-safety-signals-drive-continuous-pv-insight/index.html) May 27, 2026 #### [From Complaint Handling to Active Surveillance](/content/resources/from-complaint-handling-to-active-surveillance/index.html) May 5, 2026 #### [Continuous Safety Surveillance for Medical Devices](/content/resources/continuous-safety-surveillance-for-medical-devices/index.html) May 5, 2026 #### [Are patient outcomes getting lost in safety data complexity?](/content/resources/are-patient-outcomes-getting-lost-in-safety-data-complexity/index.html) May 5, 2026 #### [From data collection to interrogation: why 2026 is the inflection point for combination product safety surveillance](/content/resources/from-data-collection-to-interrogation-why-2026-is-the-inflection-point-for-combination-product-safety-surveillance/index.html) April 30, 2026 #### [Weight of the world: are GLP-1s breaking PV?](/content/resources/weight-of-the-world-are-glp-1s-breaking-pv/index.html) April 29, 2026 #### [Making an Impact Beena Wood](/content/resources/making-an-impact-beena-wood/index.html) April 29, 2026 #### [Regulators must intervene to drive up the quality and impact of patient safety reporting](/content/resources/regulators-must-intervene-to-drive-up-the-quality-and-impact-of-patient-safety-reporting/index.html) April 29, 2026 #### [Predicting the present What’s topping pharma’s strategic agenda for 2026?](/content/resources/predicting-the-present-whats-topping-pharmas-strategic-agenda-for-2026/index.html) April 29, 2026 #### [How AI is Transforming the Biopharmaceutical Value Chain](/content/resources/how-ai-is-transforming-the-biopharmaceutical-value-chain-how-ai-is-transforming-the-biopharmaceutical-value-chain-from-discovery-to-manufacturing/index.html) April 3, 2026 #### [Could GLP-1 obesity drugs break pharma’s safety infrastructure?](/content/resources/could-glp-1-obesity-drugs-break-pharmas-safety-infrastructure/index.html) March 3, 2026 #### [Solving safety data complexity is not an AI quick-fix](/content/resources/solving-safety-data-complexity-is-not-an-ai-quick-fix/index.html) February 23, 2026 #### [Building the Foundations for Proactive Drug Safety](/content/resources/building-the-foundations-for-proactive-drug-safety/index.html) February 11, 2026 #### [Why Data, Trust, and Skills Are the Foundations of AI-Driven Pharmacovigilance](/content/resources/why-data-trust-and-skills-are-the-foundations-of-ai-driven-pharmacovigilance/index.html) February 11, 2026 #### [Realizing the Potential of AI within the PV](/content/resources/realizing-the-potential-of-ai-within-the-pv/index.html) February 11, 2026 #### [Bio/Pharma’s Roadmap for Success in 2026](/content/resources/bio-pharmas-roadmap-for-success-in-2026/index.html) February 11, 2026 #### [Being is believing](/content/resources/being-is-believing/index.html) February 11, 2026 #### [Pharma’s operational imperatives for 2026: what next for AI, data and connected information delivery?](/content/resources/pharmas-operational-imperatives-for-2026-what-next-for-ai-data-and-connected-information-delivery/index.html) January 29, 2026 #### [Improved Drug Safety Needs Better Data Before AI](/content/resources/improved-drug-safety-needs-better-data-before-ai/index.html) January 23, 2026 #### [Trendspotting: Artificial Intelligence, Impact of Global Policies, Data Harmonization](/content/resources/trendspotting-artificial-intelligence-impact-of-global-policies-data-harmonization/index.html) January 6, 2026 #### [Leaders in Pharma: 2026 predictions](/content/resources/leaders-in-pharma-2026-predictions/index.html) December 16, 2025 #### [The Indisputable Case for AI in Pharmacovigilance](/content/resources/the-indisputable-case-for-ai-in-pharmacovigilance/index.html) December 12, 2025 #### [Digital Transformation Themes of 2025](/content/resources/digital-transformation-themes-of-2025/index.html) December 8, 2025 #### [That was the year that was](/content/resources/that-was-the-year-that-was/index.html) December 4, 2025 #### [Democratising access to signal detection](/content/resources/democratising-access-to-signal-detection/index.html) November 19, 2025 #### [Applying AI to adverse event case processing](/content/resources/applying-ai-to-adverse-event-case-processing/index.html) October 15, 2025 #### [How smaller pharma teams are rethinking safety surveillance](/content/resources/how-smaller-pharma-teams-are-rethinking-safety-surveillance/index.html) September 22, 2025 #### [Statistical Significance: Could Small Pharma make more of Signal Detection](/content/resources/statistical-significance-could-small-pharma-make-more-of-signal-detection/index.html) September 19, 2025 #### [Staying Ahead of Regulatory Revisions](/content/resources/staying-ahead-of-regulatory-revisions/index.html) September 17, 2025 #### [A Critical Inflection Point: The Indisputable Case for Next-Gen Pharmacovigilance](/content/resources/a-critical-inflection-point-the-indisputable-case-for-next-gen-pharmacovigilance/index.html) September 12, 2025 #### [AI Encompassing: From Soaring Caseloads to Broadened Biopharma Territory](/content/resources/ai-encompassing-from-soaring-caseloads-to-broadened-biopharma-territory/index.html) September 12, 2025 #### [Human and Machine: A New Standard in Pharmacovigilance](/content/resources/human-and-machine-a-new-standard-in-pharmacovigilance/index.html) September 12, 2025 #### [Powering the Pharmacovigilance Engine: Why AI’s Role is Pivotal Now](/content/resources/powering-the-pharmacovigilance-engine-why-ais-role-is-pivotal-now/index.html) August 5, 2025 #### [Qinecsa CEO featured in the Molecule to Market podcast](/content/resources/molecule-to-market-podcast-feature/index.html) July 25, 2025 #### [From Weight-loss Jabs to Ongoing Covid Vaccine Vigilance](/content/resources/ai-approach-to-pharmacovigilance-case-processing/index.html) July 14, 2025 #### [Harnessing Technology to Optimize Pharmacovigilance](/content/resources/harnessing-technology-to-optimize-pharmacovigilance/index.html) May 23, 2025 #### [Fit-for-Purpose Signal Detection Solutions for Pharmacovigilance](/content/articles/fit-for-purpose-signal-detection-solutions-for-pv/index.html) May 12, 2025 #### [Building an Automation and AI Culture](/content/articles/building-an-automation-and-ai-culture/index.html) April 24, 2025 #### [A Five-Year Roadmap for Technology-led PV Innovation](/content/resources/a-five-year-roadmap-for-technology-led-pv-innovation/index.html) April 15, 2025 #### [Navigating Drug Safety Challenges in Small Pharma and Biotech](/content/resources/navigating-drug-safety-challenges-in-small-pharma-and-biotech/index.html) March 31, 2025 #### [Industry Outlook 2025 – Part 2: Shifting Political Landscapes](/content/articles/industry-outlook-2025-part-2/index.html) January 30, 2025 #### [Industry Outlook 2025 – Part 1: Through the Lens of a Service Provider](/content/articles/industry-outlook-2025/index.html) January 29, 2025 #### [PharmaVoice’s Crystal Ball: The industry’s AI future](/content/articles/pharmavoices-crystal-ball/index.html) January 7, 2025 #### [Drug Solutions Podcast: Realizing AI’s Potential](/content/articles/drug-solutions-podcast/index.html) December 20, 2024 #### [What is Pharmacovigilance?](/content/articles/what-is-pharmacovigilance/index.html) August 30, 2024 #### [Integrating Medical Devices into Pharmacovigilance Portfolios](/content/resources/integrating-medical-devices-into-pharmacovigilance-portfolios/index.html) July 11, 2024 #### [Qinecsa featured in International Pharmaceutical Industry (IPI) editorial](/content/articles/qinecsa-featured-in-international-pharmaceutical-industry-ipi/index.html) July 11, 2024 #### [Shaping the Future of Clinical Research Technology](/content/resources/outsourcing-pharma-feature-clinical-research-technology/index.html) July 10, 2024 #### [Embracing a New Future-Ready Pharmacovigilance Ecosystem](/content/resources/embracing-a-new-future-ready-pharmacovigilance-ecosystem/index.html) July 10, 2024 #### [Qinecsa shares latest innovations with industry media before DIA Global Annual Meeting 2024](/content/articles/qinecsa-share-latest-innovations-with-industry-media-before-dia-global-annual-meeting-2024/index.html) June 13, 2024 #### [Report: The Dynamics of Drug Safety in Small Pharma, Biotech, and Medical Devices](/content/articles/pv-insights-network-benchmarking-report-the-dynamics-of-drug-safety-in-small-pharma-biotech-and-medical-devices/index.html) April 9, 2024 #### [Fit-for-Future Sourcing for Pharmacovigilance: Embracing Change for Success](/content/articles/fit-for-future-sourcing-for-pharmacovigilance/index.html) June 15, 2023 #### [Transforming Data into Decisions](/content/articles/transforming-data-into-decisions/index.html) March 18, 2023 #### [Qinecsa Pharmacovigilance Consulting Guide](/content/articles/qinecsa-pharmacovigilance-consulting-guide/index.html) December 13, 2022